NEW YORK, Jan. 9, 2017 /PRNewswire/ -- Report Details
Pre-Filled Syringes and Related Drug Delivery – Discover Leading Companies' Revenue Potentials
How are companies in the pre-filled syringe industry performing? Visiongain's new report gives you data, analysis and discussions for producers of those drug delivery devices.
Our study lets you assess companies in the pre-filled (ready-to-fill) syringe industry and market, showing you their prospects to 2026. There you see financial results, opinion, trends, opportunities and sales predictions.
That way you discover potentials of established and rising companies. Read on, please, to scan those organisations and see what their future market could be worth.
Forecasts and discussions to help you stay ahead in knowledge and authority
Our new study assesses 25 top companies – and analyses that overall industry – with sales results, revenue forecasts and growth rates. In our 230 page report you gain 86 tables, 30 charts and a research interview.
You also get qualitative analyses, including research and development. Our work lets you assess the most beneficial and lucrative applications of those drug delivery technologies. There you see opportunities for producers of medical injection devices and manufacturers of biologics, insulins and vaccines.
That way you stay ahead in knowledge of the industry and market for these medical devices, helping your influence. You explore leading developers, producers and marketers of these products:
- Plastic and glass pre-filled syringes
- Pen injectors and autoinjectors, including insulin delivery
- Related components and safety systems, including needles, shields, Luer fitments, plungers and tip caps
- Contract manufacturing organisations (CMOs) providing filling services for pre-filled injection devices (syringes and cartridges).
The following sections describe how our new investigation helps your work.
Company profiles – discover why firms succeed, also exploring their prospects
Our report profiles 25 leading companies worldwide across four segments of the pre-filled injection devices market. The content of each discussion differs, depending on the company. In general a profile contains the following information:
- Overview of the firm, showing its place in the pre-filled injection devices field
- Discussion of the company's product or service portfolio, including clients
- Analysis of the player's recent financial performance, esp. relevant sales
- Coverage of developments – e.g. acquisitions, R&D, expansions, launches and collaborations with the pharmaceutical industry
- Prospects of the company – strengths over competitors and opportunities
- Prediction of revenue for the period 2016-2026 (for 10 companies).
Our survey shows how product and service demand changed in recent years, as well as explaining how those needs can develop from 2016 – rising demand.
Prospects for leading pre-filled syringe manufacturers
Our study gives you discussions and financial analyses for developers and producers of pre-filled injection devices - these five leaders and other firms:
- Becton, Dickinson & Co. (BD)
There you discover what the future holds for those medical device companies, seeing how they compare and compete. You find where the best prospects for business exist.
Suppliers and users of pre-filled injection systems will benefit from 2016. Next, our work analyses developers, producers and providers of associated technology.
Outlooks for manufacturers of pre-filled syringe components
The report shows you developments and revenue prospects for leading producers of syringe components and related accessories, including these companies:
- Aptar Stelmi
- Dätwyler Holding
- West Pharmaceutical Services.
In our study you explore opportunities for companies making injection safety systems, plungers, needle shields, caps and related products.
Our work shows you where sales growth can occur. Many opportunities remain, with expanding revenues likely from 2016 to 2026. See what is possible.
Potentials of leading pen injector and autoinjector producers
In our study you also see commercial outlooks for top manufacturers of pen injectors and autoinjectors, including these companies:
- Owen Mumford
- SHL Group
There you assess product portfolios, strategies and revenue prospects. You also investigate associated organisations and competition. Our work shows you possibilities for advancing technologies and raising sales.
Contract manufacturers in that parenteral drug delivery
Our work also assesses contract manufacturing organisations (CMOs) in that field. There you explore these production service providers and others:
- Hospira One2One
- Vetter Pharma.
That way you assess the capabilities and outlooks of healthcare CMOs in that field. You also scan applications for biological drugs (biologics), lyophilisation and dual-chamber syringes, among other advances.
Value of that market in 2020 – what sales growth is possible and why?
Our analysis predicts overall world revenues for those pre-filled injection devices – the drug delivery technology – will reach $6940m in 2020. Those sales will expand further to 2026, showing strong revenue growth. Many opportunities remain.
Greater use of biologics and vaccines raise demand for parenteral delivery systems. Many opportunities exist, especially for plastic syringes, polymers and ready-to-use containment of labile drugs and other complex pharmaceuticals. Our study explains.
What about applications? Rising incidence of diabetes and expansion of the home healthcare market stimulate demand for pre-filled injection products. Explore what is possible, staying ahead. In our study you see what those companies' futures hold.
5 ways Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2016-2026 helps your work
In particular our new investigation gives you this knowledge to benefit your research, analyses, plans and presentations:
- Profiles of 25 leading companies – assess their products, technologies, activities, partnerships, developments and results
- Forecast revenue to 2026 for that overall market at world level – discover expected sales rises for pre-filled drug delivery devices and services
- Predicted revenues for top companies – see potential sales to 2026 for 10 leading participants
- Competition and opportunities – explore what affects that industry, seeing forces that influence its sales and determine its future
- Opinion from an interview with a leading company – gain insight to help you stay ahead in knowledge, benefiting your reputation for insight.
That study, by our in-house analysts in the UK, has the purpose of helping your work. There you gain data and insight you find nowhere else, to help you succeed.
Independent analysis to benefit your authority on pre-filled drug delivery
Our work gives independent analysis. There you receive business intelligence found only in that report, seeing where technological and financial prospects are most rewarding, as well as companies' potentials from 2016 to 2026.
With our study you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses and decisions, also saving time and gaining in authority. Explore that industry's future, seeing what is possible and how you can gain.
Our new investigation is for everyone assessing the industry and market for drug delivery by injection. There you find data, trends, opportunities and forecasts. Avoid missing out. Benefit in knowledge and influence by requesting our report now.
Read the full report: http://www.reportlinker.com/p02148692-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/medical-device-leader-series-top-pre-filled-injection-device-manufacturers-2016-2026-300388043.html